menu
    • menu
    [{"orgOrder":0,"company":"OMEICOS Therapeutics GmbH","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Genetic Disease","country":"","productType":"Small molecule","year":"2024","type":"Not Applicable","leadProduct":"OMT-28","moa":"","graph1":"Technology","graph2":"Phase I\/II","graph3":"OMEICOS Therapeutics GmbH","amount2":0,"highestDevelopmentShortName":"","therapeuticAreaShortName":"Technology","amount2New":0.94999999999999996,"dosageForm":"","sponsorNew":"OMEICOS Therapeutics GmbH \/ Not Applicable","highestDevelopmentStatusID":"14","companyTruncated":"OMEICOS Therapeutics GmbH \/ Not Applicable"}]

    Find Clinical Drug Pipeline Developments & Deals for OMT-28

    Menu

    OMT-28

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            OMEICOS Therapeutics GmbH

                            Germany arrow
                            Pharmtech & Ingredients
                            Not Confirmed

                            OMEICOS Therapeutics GmbH

                            Germany arrow
                            Pharmtech & Ingredients
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : OMT-28

                            Therapeutic Area : Genetic Disease

                            Study Phase : Phase II

                            Sponsor : Not Applicable

                            Deal Size : Not Applicable

                            Deal Type : Not Applicable

                            DEALS_DEV arrow-down

                            OMEICOS Completes Enrollment of PMD-OPTION Study in Primary Mitochondrial Disease

                            Details : OMT-28 is a first-in-class PPARα agonist small molecule drug candidate, which is currently being evaluated for the treatment of primary mitochondrial disease.

                            Brand Name : OMT-28

                            Molecule Type : Small molecule

                            Upfront Cash : Not Applicable

                            September 26, 2024

                            Lead Product(s) : OMT-28

                            Therapeutic Area : Genetic Disease

                            Highest Development Status : Phase II

                            Sponsor : Not Applicable

                            Deal Size : Not Applicable

                            Deal Type : Not Applicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth